Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells

Antiestrogenic adjuvant treatments are first-line therapies in patients with breast cancer positive for estrogen receptor (ER+). Improvement of their treatment strategies is needed because most patients eventually acquire endocrine resistance and many others are initially refractory to anti-estrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellaro, Andrés M., Rodriguez-Baili, María C., Di Tada, Cecilia E., Gil, Germán A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406935/
https://www.ncbi.nlm.nih.gov/pubmed/30736340
http://dx.doi.org/10.3390/cancers11020189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406935/
https://www.ncbi.nlm.nih.gov/pubmed/30736340
http://dx.doi.org/10.3390/cancers11020189

Ejemplares similares